Breaking News Instant updates and real-time market news.

TEVA

Teva

$37.86

-0.29 (-0.76%)

08:09
11/30/16
11/30
08:09
11/30/16
08:09

Teva to present data on Granix, Treanda, Trisenox injections at ASH meeting

Teva announced that data on GRANIX Injection, TREANDA Injection and TRISENOX Injection will be presented during poster sessions at the 2016 ASH Annual Meeting to be held at the San Diego Convention Center in San Diego, CA on December 3-6, 2016. Additional bendamustine abstracts were also accepted for publication in an online issue of Blood to be issued during the annual meeting. "We look forward to sharing real world data and outcomes research from our Oncology portfolio that provide deeper insights into our products," said Richard Nieman, M.D., SVP, Global Medical Affairs, Teva Pharmaceuticals. "The presentations at this year's ASH Meeting further highlight Teva's commitment to providing innovative medicines that positively impact our healthcare system, treatment and management of disease, and the lives of people, particularly those affected by cancer."

TEVA Teva
$37.86

-0.29 (-0.76%)

11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MAXM
11/17/16
NO CHANGE
Target $52
MAXM
Buy
Teva price target lowered to $52 from $72 at Maxim
Maxim analyst Gabrielle Zhou lowered her price target for Teva to $52 from $72 after the company reported Q3 results and cut it full-year guidance. The analyst notes that the company has started its Actavis integration, with the latter now contributing to Teva's generic revenues. However, she believes Teva needs to focus now on growth, noting that 2017 will be a challenge. Zhou reiterates a Buy rating on Teva's shares.
11/22/16
LEER
11/22/16
NO CHANGE
LEER
Outperform
Alder Biopharmaceuticals patent fight far from over, says Leerink
Leerink analyst Joseph Schwartz says Alder Biopharmaceuticals (ALDR) stated that the European Patent Office issued a ruling revoking all claims in its competitor Teva's (TEVA) patent relating to CGRP antagonist antibodies but maintaining and narrowing claims relating to the use of CGRP antagonist antibodies in human therapy to the prevention or treatment of headache such as migraine and cluster headache. The analyst notes that the persistence of the headache claims has concerned investors, but points out that Alder believes the patent fight is far from over in the EU, or moreover in the U.S. Schwartz reiterates an Outperform rating on Alder's shares.
11/25/16
PIPR
11/25/16
NO CHANGE
Target $47
PIPR
Overweight
Alder recent selloff an overreaction, says Piper Jaffray
Piper Jaffray analyst Charles Duncan attributes the recent weakness in shares of Alder Biopharmaceuticals (ALDR) to "increased visibility and outcome uncertainty" for the company's challenge to Teva's (TEVA) anti-CGRP patents in the U.S. and Europe. The analyst views the selloff as an overreaction and remains focused on his "clinical data-driven thesis for the emerging, differentiated profile of lead candidate ALD403." Duncan keeps an Overweight rating on Alder with a $47 price target.

TODAY'S FREE FLY STORIES

OSUR

OraSure

$15.72

0.17 (1.09%)

14:59
06/27/17
06/27
14:59
06/27/17
14:59
Recommendations
OraSure analyst commentary  »

OraSure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

GG

Goldcorp

$13.43

-0.24 (-1.76%)

, XRA

Exeter Resource

14:56
06/27/17
06/27
14:56
06/27/17
14:56
Hot Stocks
Goldcorp agrees to acquire all Exeter Resource shares it does not already own »

Goldcorp (GG) announced…

GG

Goldcorp

$13.43

-0.24 (-1.76%)

XRA

Exeter Resource

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

KBH

KB Home

$23.04

0.26 (1.14%)

14:49
06/27/17
06/27
14:49
06/27/17
14:49
Options
KB Home options imply 6.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CMCSA

Comcast

$39.59

0.09 (0.23%)

, CMCSK

Comcast

14:41
06/27/17
06/27
14:41
06/27/17
14:41
Periodicals
NBC Sports to offer Premier League streaming package, Recode says »

NBCUniversal's NBC…

CMCSA

Comcast

$39.59

0.09 (0.23%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

CF

CF Industries

$27.08

-0.33 (-1.20%)

14:30
06/27/17
06/27
14:30
06/27/17
14:30
Options
CF sees call buying »

CF sees call buying. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
06/27/17
06/27
14:30
06/27/17
14:30
General news
Yellen reiterated the Fed's commitment to price stability »

Yellen reiterated the…

MLHR

Herman Miller

$29.50

0.1 (0.34%)

14:27
06/27/17
06/27
14:27
06/27/17
14:27
Initiation
Herman Miller initiated  »

Herman Miller initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

DECK

Deckers Brands

$67.76

0.82 (1.23%)

14:26
06/27/17
06/27
14:26
06/27/17
14:26
Hot Stocks
Marcato confirms letter to Deckers, says prepared to seek board ouster »

Marcato Capital, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$27.67

3.43 (14.15%)

14:25
06/27/17
06/27
14:25
06/27/17
14:25
Options
Avis Budget call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$67.54

0.6018 (0.90%)

14:20
06/27/17
06/27
14:20
06/27/17
14:20
Periodicals
Marcato threatens proxy fight at Deckers Brands, CNBC reports »

CNBC's Leslie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
06/27/17
06/27
14:17
06/27/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$242.12

-1.1728 (-0.48%)

, SPX

S&P 500

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Technical Analysis
Technical View: S&P 500 takes out channel low »

The S&P 500 (SPX) has…

SPY

SPDR S&P 500 ETF Trust

$242.12

-1.1728 (-0.48%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$67.53

0.59 (0.88%)

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Periodicals
Marcato threatens proxy fight at Deckers Brands, CNBC reports 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$34.59

-0.565 (-1.61%)

14:15
06/27/17
06/27
14:15
06/27/17
14:15
Options
AstraZeneca put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

14:10
06/27/17
06/27
14:10
06/27/17
14:10
General news
Treasury Action: Fed chair Yellen hasn't said anything on the policy path »

Treasury Action: Fed…

AIII

ACRE Realty Investors

14:09
06/27/17
06/27
14:09
06/27/17
14:09
Hot Stocks
Breaking Hot Stocks news story on ACRE Realty Investors »

ACRE Realty Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDG

TransDigm

$264.99

-3.26 (-1.22%)

14:05
06/27/17
06/27
14:05
06/27/17
14:05
Hot Stocks
TransDigm slips after Capitol Forum says DLA confirms active probe »

Shares of TransDigm are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENFC

Entegra Financial

$23.40

0.25 (1.08%)

14:04
06/27/17
06/27
14:04
06/27/17
14:04
Downgrade
Entegra Financial rating change  »

Entegra Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIII

ACRE Realty Investors

14:01
06/27/17
06/27
14:01
06/27/17
14:01
Hot Stocks
ACRE Realty Investors announces board approval of dissolution »

ACRE Realty Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.72

-0.4349 (-1.14%)

13:55
06/27/17
06/27
13:55
06/27/17
13:55
Options
AT&T put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/27/17
06/27
13:55
06/27/17
13:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

13:54
06/27/17
06/27
13:54
06/27/17
13:54
General news
Senate GOP leaders delay healthcare vote until after July 4 recess, AP says 

Reference Link

13:53
06/27/17
06/27
13:53
06/27/17
13:53
General news
Market takes downturn, moves to session lows »

After moving in a narrow…

XRA

Exeter Resource

$1.61

-0.01 (-0.62%)

, GG

Goldcorp

$13.44

-0.23 (-1.68%)

13:51
06/27/17
06/27
13:51
06/27/17
13:51
Hot Stocks
Exeter Resource, Goldcorp enter agreement to proceed with acquisition »

Exeter Resource (XRA) has…

XRA

Exeter Resource

$1.61

-0.01 (-0.62%)

GG

Goldcorp

$13.44

-0.23 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.